vs
CORCEPT THERAPEUTICS INC（CORT）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是STURM RUGER & CO INC的1.3倍（$202.1M vs $151.1M），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 3.6%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $12.3M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 5.1%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
CORT vs RGR — 直观对比
营收规模更大
CORT
是对方的1.3倍
$151.1M
营收增速更快
CORT
高出7.5%
3.6%
自由现金流更多
CORT
多$26.1M
$12.3M
两年增速更快
CORT
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $151.1M |
| 净利润 | $24.3M | — |
| 毛利率 | 98.7% | 17.8% |
| 营业利润率 | 2.2% | 2.3% |
| 净利率 | 12.0% | — |
| 营收同比 | 11.1% | 3.6% |
| 净利润同比 | -21.0% | — |
| 每股收益（稀释后） | $0.20 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTRGR
| Q4 25 | $202.1M | $151.1M | ||
| Q3 25 | $207.6M | $126.8M | ||
| Q2 25 | $194.4M | $132.5M | ||
| Q1 25 | $157.2M | $135.7M | ||
| Q4 24 | $181.9M | $145.8M | ||
| Q3 24 | $182.5M | $122.3M | ||
| Q2 24 | $163.8M | $130.8M | ||
| Q1 24 | $146.8M | $136.8M |
净利润CORTRGR
| Q4 25 | $24.3M | — | ||
| Q3 25 | $19.7M | $1.6M | ||
| Q2 25 | $35.1M | $-17.2M | ||
| Q1 25 | $20.5M | $7.8M | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $47.2M | $4.7M | ||
| Q2 24 | $35.5M | $8.3M | ||
| Q1 24 | $27.8M | $7.1M |
毛利率CORTRGR
| Q4 25 | 98.7% | 17.8% | ||
| Q3 25 | 97.8% | 15.1% | ||
| Q2 25 | 98.2% | 3.9% | ||
| Q1 25 | 98.5% | 22.0% | ||
| Q4 24 | 98.4% | 22.8% | ||
| Q3 24 | 98.4% | 18.5% | ||
| Q2 24 | 98.5% | 22.3% | ||
| Q1 24 | 98.3% | 21.5% |
营业利润率CORTRGR
| Q4 25 | 2.2% | 2.3% | ||
| Q3 25 | 4.9% | -2.7% | ||
| Q2 25 | 13.7% | -15.6% | ||
| Q1 25 | 2.2% | 6.2% | ||
| Q4 24 | 13.9% | 7.8% | ||
| Q3 24 | 25.5% | 3.1% | ||
| Q2 24 | 21.7% | 6.9% | ||
| Q1 24 | 20.1% | 5.5% |
净利率CORTRGR
| Q4 25 | 12.0% | — | ||
| Q3 25 | 9.5% | 1.2% | ||
| Q2 25 | 18.1% | -13.0% | ||
| Q1 25 | 13.1% | 5.7% | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 25.9% | 3.9% | ||
| Q2 24 | 21.7% | 6.3% | ||
| Q1 24 | 18.9% | 5.2% |
每股收益（稀释后）CORTRGR
| Q4 25 | $0.20 | $0.22 | ||
| Q3 25 | $0.16 | $0.10 | ||
| Q2 25 | $0.29 | $-1.05 | ||
| Q1 25 | $0.17 | $0.46 | ||
| Q4 24 | $0.25 | $0.62 | ||
| Q3 24 | $0.41 | $0.28 | ||
| Q2 24 | $0.32 | $0.47 | ||
| Q1 24 | $0.25 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $283.8M |
| 总资产 | $836.7M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTRGR
| Q4 25 | $372.2M | $92.5M | ||
| Q3 25 | $421.7M | $80.8M | ||
| Q2 25 | $342.2M | $101.4M | ||
| Q1 25 | $322.8M | $108.3M | ||
| Q4 24 | $383.3M | $105.5M | ||
| Q3 24 | $380.3M | $96.0M | ||
| Q2 24 | $473.2M | $105.6M | ||
| Q1 24 | $410.8M | $115.3M |
股东权益CORTRGR
| Q4 25 | $647.8M | $283.8M | ||
| Q3 25 | $631.9M | $279.6M | ||
| Q2 25 | $635.8M | $289.3M | ||
| Q1 25 | $683.3M | $321.5M | ||
| Q4 24 | $679.6M | $319.6M | ||
| Q3 24 | $638.8M | $314.9M | ||
| Q2 24 | $596.2M | $321.5M | ||
| Q1 24 | $547.9M | $332.0M |
总资产CORTRGR
| Q4 25 | $836.7M | $342.0M | ||
| Q3 25 | $823.6M | $342.3M | ||
| Q2 25 | $801.7M | $349.5M | ||
| Q1 25 | $846.5M | $379.0M | ||
| Q4 24 | $840.6M | $384.0M | ||
| Q3 24 | $784.3M | $373.5M | ||
| Q2 24 | $714.6M | $376.7M | ||
| Q1 24 | $655.9M | $385.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $12.3M |
| 自由现金流率自由现金流/营收 | 19.0% | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | $38.5M |
8季度趋势，按日历期对齐
经营现金流CORTRGR
| Q4 25 | $38.4M | $15.5M | ||
| Q3 25 | $54.5M | $12.9M | ||
| Q2 25 | $43.9M | $14.7M | ||
| Q1 25 | $5.1M | $11.1M | ||
| Q4 24 | $59.3M | $20.0M | ||
| Q3 24 | $73.8M | $9.4M | ||
| Q2 24 | $41.2M | $18.7M | ||
| Q1 24 | $23.8M | $7.3M |
自由现金流CORTRGR
| Q4 25 | $38.4M | $12.3M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | $43.9M | $9.1M | ||
| Q1 25 | $5.0M | $10.0M | ||
| Q4 24 | $59.2M | $16.4M | ||
| Q3 24 | $72.2M | $2.6M | ||
| Q2 24 | $40.8M | $10.1M | ||
| Q1 24 | — | $5.6M |
自由现金流率CORTRGR
| Q4 25 | 19.0% | 8.2% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | 22.6% | 6.9% | ||
| Q1 25 | 3.2% | 7.4% | ||
| Q4 24 | 32.5% | 11.2% | ||
| Q3 24 | 39.5% | 2.1% | ||
| Q2 24 | 24.9% | 7.7% | ||
| Q1 24 | — | 4.1% |
资本支出强度CORTRGR
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 4.2% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.1% | 2.5% | ||
| Q3 24 | 0.9% | 5.5% | ||
| Q2 24 | 0.3% | 6.6% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率CORTRGR
| Q4 25 | 1.58× | — | ||
| Q3 25 | 2.77× | 8.15× | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 0.25× | 1.43× | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | 1.98× | ||
| Q2 24 | 1.16× | 2.27× | ||
| Q1 24 | 0.86× | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
